Skip to content

Blue Shield California July 2017 Medical Policy Updates

Click here to view the BlueShield California July 2017 Medical Policy Updates »

New and Updated Policies
Effective July 1, 2017

  • Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms
  • Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry
  • Balloon Ostial Dilation for Treatment of Chronic Rhinosinusitis
  • Baroreflex Stimulation Devices
  • Biventricular Pacemakers (Cardiac Resynchronization Therapy) for the Treatment of Heart Failure
  • Blepharoplasty, Blepharoptosis Repair (Levator Resection) and Brow Lift (Repair of Brow Ptosis)
  • Breast Implant Management
  • Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient Setting
  • Catheter Ablation as Treatment for Atrial Fibrillation
  • Closure Devices for Patent Foramen Ovale and Atrial Septal Defects
  • Computerized 2-Lead Resting Electrocardiogram Analysis for the Diagnosis of Coronary Artery Disease
  • Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid
  • Continuous Passive Motion in the Home Setting
  • Deep Brain Stimulation
  • Endovascular Stent Grafts for Abdominal Aortic Aneurysms
  • Endovascular Stent Grafts for Disorders of the Thoracic Aorta
  • Endovascular Therapies for Extracranial Vertebral Artery Disease
  • Extracorporeal Membrane Oxygenation for Adult Conditions
  • Extracranial Carotid Artery StentingFocal Treatments for Prostate Cancer
  • Gender Reassignment Surgery
  • Genetic Testing for Hereditary Hemochromatosis
  • Genetic Testing for Inherited Thrombophilia
  • Genetic Testing for Limb-Girdle Muscular Dystrophies
  • Heart Transplant
  • Heart/Lung Transplant
  • Hematopoietic Cell Transplantation for Solid Tumors of Childhood
  • Hip Resurfacing
  • Implantable Cardioverter Defibrillator
  • Inhaled Nitric Oxide
  • Intradialytic Parenteral Nutrition
  • Intraoperative Neurophysiologic Monitoring
  • KIF6 Genotyping for Predicting Cardiovascular Risk and/or Effectiveness of Statin Therapy
  • Lipid Apheresis
  • Magnetic Resonance Imaging for Detection and Diagnosis of Breast Cancer
  • Microwave and Locoregional Laser Tumor Ablation
  • Molecular Testing in the Management of Pulmonary Nodules
  • Neuropsychological Testing
  • Noninvasive Fetal RHD Genotyping Using Cell-Free Fetal DNA
  • Open and Thoracoscopic Approaches to Treat Atrial Fibrillation and Atrial Flutter (Maze and Related Procedures)
  • Orthognathic Surgery
  • Panniculectomy, Abdominoplasty, and Surgical Management of Diastasis Recti
  • Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
  • Percutaneous Vertebroplasty and Sacroplasty
  • Pharmacogenetic Testing for Pain Management
  • Reconstructive Services
  • Sphenopalatine Ganglion Block for Headache
  • ST2 Assay for Chronic Heart Failure and Heart Transplant Rejection
  • Steroid Injections to the Knee and/or Shoulder
  • Transcatheter Mitral Valve Repair
  • Treatment of Varicose Veins/Venous Insufficiency
  • Ultrafiltration in Decompensated Heart Failure
  • Wearable Cardioverter Defibrillators

Click here to view the BlueShield California July 2017 Medical Policy Updates »

 

Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!

Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.

Create your account

Complete the form below to create your Policy Alerts Dashboard account.

  • No Payment Information Required
    By clicking “Submit” you agree to our Terms of Service and Privacy Policy.
  • This field is for validation purposes and should be left unchanged.

Create your account

Complete the form below to create your Policy Alerts Dashboard account.

  • Strength indicator
  • No Payment Information Required
    By clicking “Submit” you agree to our Terms of Service and Privacy Policy.
  • This field is for validation purposes and should be left unchanged.

Create your account

Complete the form below to create your Policy Alerts Dashboard account.

  • Strength indicator
  • No Payment Information Required
    By clicking “Submit” you agree to our Terms of Service and Privacy Policy.
  • This field is for validation purposes and should be left unchanged.

Create your account

Complete the form below to create your Policy Alerts Dashboard account.

  • Strength indicator
  • No Payment Information Required
    By clicking “Submit” you agree to our Terms of Service and Privacy Policy.
  • This field is for validation purposes and should be left unchanged.

Back To Top